Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'
One daysingle sourceOne outlet reported this themselves - 9 of the 10 reports ran its copy.
The headline, as it travelled
All 10 reports used the same wording across 10 outlets - nobody re-reported it in their own words.
All 10 reports on Fri, 7 August 2026
What it is about
ResearchersKalshiPolymarketJoshua PedersonAnne WojcickiNicholas ZaorskyGeorge SantosDavid TsaiDrug AdministrationAmericansChineseVenezuelanBoston, Massachusetts, United StatesFred Tanneau
Who published it, and when
original reportcopy
houstonpublicmedia.org
wbaa.org
kmxt.org
wncw.org
kzyx.org
kuaf.com
wfdd.org
kacu.org
wkyufm.org
7 Aug, 06:00over 4 hours7 Aug, 10:00
1 report left out of the cascade - too little in common with the story to place
How it spread - 1 original report, 9 reprints
Fri, 7 August 2026
1 report- NPR News10:00
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
9 reprints
- houstonpublicmedia.org7 Aug, 06:00their copy
- wbaa.org7 Aug, 10:00their copy
- kmxt.org7 Aug, 10:00their copy
- wncw.org7 Aug, 10:00their copy
- kzyx.org7 Aug, 10:00their copy
- kuaf.com7 Aug, 10:00their copy
- wfdd.org7 Aug, 10:00their copy
- kacu.org7 Aug, 10:00their copy
- wkyufm.org7 Aug, 10:00their copy